TWST

#1255
Twist Bioscience Corporation - Common Stock
66.8 7 USD
-3.13%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
66.87
66.87
1年のレンジ
23.30
69.20
1日の変化
-3.13%
月次変化
+16.30%
6か月変化
+114.05%
1年の変化
+133.73%
以前の終値
69.0 3
Open
66.8 7
安値
66.8 7
High
66.8 7
ボリューム
165
チャート全体を表示 Full chart

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 4.16 B
  • Employee 979
  • Founded 2013
  • CEO Emily LeProust
  • Website www.twistbioscience.com
  • Headquarter Delaware, United States
  • FIGI BBG006KDCHJ4
  • Industry 診断・研究
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-21.65
売上高対価格比率
4.47

Twist Bioscience Corporation - Common Stock

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.

ニュース